期刊文献+

低剂量氯吡格雷在冠状动脉再狭窄家猪模型中应用的初步探讨

The initial use investigation of lower dose clopidogrel in the domestic porcine model for coronary artery restenosis
下载PDF
导出
摘要 目的评价低剂量氯吡格雷在冠状动脉再狭窄家猪模型中的应用效果。方法选取健康家猪6头,抽取静脉血测定ADP(Adenosine Diphosphate,二磷酸腺苷)诱导的血小板聚集率作为基础值,然后开始喂食氯吡格雷(25mg/d)和常规剂量的阿司匹林,开始给药后第4天行介入手术构建冠状动脉过度扩张再狭窄模型并行支架植入术,同时在给药后第4、8﹑14天再次抽血测定ADP诱导的血小板聚集率,评价氯吡格雷对血小板聚集率的抑制效果,记录术后压迫止血情况及术中、术后的安全性,14天时处死动物并血管取材评价支架内血栓情况。采用SPSS10.0进行统计学分析。结果家猪平均体重为(23.1±4.4)Kg,ADP诱导的血小板聚集率基础值为(43.08±5.06)%。用药后第4天,血小板聚集率值较基础值明显下降[(29.05±9.26)%:(43.08±5.06)%,P=0.008],用药后8天血小板聚集率值进一步下降,用药后14天,血小板聚集率值趋于稳定,达到并维持抗血小板聚集的效果,术中和术后24小时均未发生冠状动脉事件,14天时血管取材病理切片未见支架内血栓形成。结论在冠状动脉再狭窄家猪模型中,低剂量氯吡格雷可以达到抑制ADP诱导的血小板聚集的效果,同时低剂量氯吡格雷联合常规剂量的阿司匹林可以保证冠状动脉再狭窄家猪模型的安全性,并降低实验费用。 Objective To investigate the effect and safety of the lower clopidogrel in domestic porcine model for coronary artery restenosis.Methods We took the 6 samples of domestic porcine blood and measured the inhibition of platelet aggregation value before administration of Clopidogrel and 4-day,8-day,14-day after administration.4-day after administration,we build the porcine model for coronary artery restenosis and implant stents.We evaluate the effects of inhibition of platelet aggregation induced by ADP,compression hemostasis and safety of peri-operation.The data were analyzed with SPSS 10.0.Result 4-day after administration the value of inhibition of platelet aggregation is lower than base line significantly,[(29.05±9.26)% vs.(43.08±5.06)%,P=0.008].8-day,14-day after administration,the inhibitions of Platelet Aggregation are still low.No peri-operation coronary events were found.After 14-day,no thrombosis was found in the pathological sections.Conclusions Our data demonstrates that administration of Clopidogrel 25 mg/d can inhibit platelet aggregation induced by ADP,administration of Clopidogrel 25 mg/d combining with routine aspirin may provide the peri-operation safety and reduce the cost in the domestic porcine model for coronary artery restenosis.
出处 《中国医学前沿杂志(电子版)》 2011年第6期45-48,共4页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
关键词 再狭窄 猪模型 血小板聚集率 Restenosis Platelet aggregation Clopidogrel Domestic porcine model
  • 相关文献

参考文献6

  • 1Gronstein BN;Naime D;Ostad E.The antiinflammtory mechanism of methotrexate:increased adenosine release at infl amed sites diminishes leukocyte accumulation in an in vivo model of inflammation[J]Journal of Clinical Investigation,1993(06):2675-2682.
  • 2Schwartz RS;Huber KC;Murphy JG.Restenosis and the proportional neointimal response to coronary artery injury:Results in a porcine model[J]Journal of the American College of Cardiology,1992(02):267-274.
  • 3Quinn MJ;Fitzgerald DJ.Ticlopidine andclopidogrel[J]Circulation,1999(15):1667-1672.
  • 4Takallapalli Ramesh;Kumar Rao;P.Rani Usha;M.U.R.Naidu.Bioequivalence and tolerability study of two brands of clopidogrel tablets,using inhibition of platelet aggregation and pharmacodynamic measures[J]Current Therapeutic Research,2003(09):685-696.
  • 5蒋利.药物洗脱支架时代的抗血小板治疗[J].世界临床药物,2007,28(3):142-146. 被引量:1
  • 6刁繁荣,吕安林,李军杰,宋延彬,温俊娜,孟晓雪.雷帕霉素-替罗非班复合药物涂层支架预防支架内血栓和再狭窄的实验研究[J].心脏杂志,2007,19(4):384-387. 被引量:13

二级参考文献13

  • 1张莉莉,贾国良,王海昌,郭文怡,马兰香,孙玉波.抗血小板药物对冠心病支架植入术后再狭窄防治效果的观察[J].心脏杂志,2004,16(5):459-461. 被引量:9
  • 2李慧丽,万锕俊,王彬尧,黄定九.药物涂层支架的研究进展[J].心脏杂志,2004,16(5):476-479. 被引量:4
  • 3吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 4Grech ED. ABC of interventional cardiology: Percutaneous coronary intervention. I: history and development [ J ]. BMJ, 2003, 326 (7398) :1080 - 1082.
  • 5Morice MC, Serruys PW, Sousa JE,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[ J]. N Engl J Med, 2002,346(23) :1773 - 1780.
  • 6Nakatani M, Takeyama Y, Shibata M, et al. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting[ J]. Cardiovasc Pathol, 2003,12( 1 ) : 40 -48.
  • 7Drachman DE, Simon DI. Inflammation as a mechanism and therapeutic target for in-stent restenosis[ J ]. Curr Atheroscler Rep ,2005,7 (1) :44 -49.
  • 8Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost versus clinical benefit [ J ]. Circulation, 2003,107 (24) :3003 - 3007.
  • 9Kereiakes DJ. Hippocrates revisited: the evidence for drug-eluting stents [ J ]. Circulation ,2003,107 (24) :3012 - 3014.
  • 10Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? [ J ]. Circulation, 2004,109 ( 6 ) :701 - 705.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部